Summit Therapeutics (SMMT) Interest & Investment Income (2017 - 2023)

Summit Therapeutics (SMMT) has 5 years of Interest & Investment Income data on file, last reported at $968000.0 in Q1 2023.

• Quarterly Interest & Investment Income changed N/A year-over-year to $968000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$2.6 million (up 27.05% YoY) and the FY2019 annual result came in at $5142.9, changed N/A from the prior year.
• Interest & Investment Income climbed to $968000.0 in Q1 2023, from $1281.9 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $968000.0 in Q1 2023 to a low of -$3.6 million in Q4 2019.
• A 3-year average of -$520752.7 and a median of $1281.9 in 2020 frame the typical range for Interest & Investment Income.
• The widest YoY moves for Interest & Investment Income: up 50.77% in 2020, down 50.77% in 2020.
• Tracing SMMT's Interest & Investment Income over 3 years: stood at -$3.6 million in 2019, then surged by 100.04% to $1281.9 in 2020, then surged by 75414.97% to $968000.0 in 2023.
• The last three Interest & Investment Income figures came in at $968000.0 (Q1 2023), $1281.9 (Q1 2020), and -$3.6 million (Q4 2019), per Business Quant data.